Vaginoscopy Compared to Traditional Hysteroscopy for Hysteroscopy Morcellation in Outpatient Clinic. A Randomized Trial
NCT ID: NCT04373694
Last Updated: 2023-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
78 participants
INTERVENTIONAL
2020-09-09
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy
NCT05967936
The Hysteroscopic Morcellator (HM).
NCT01537822
Evaluation of the Uterine Cavity After Operative Hysteroscopy
NCT06924437
Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy
NCT02472197
Evaluation of Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease
NCT06576362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. traditional hysteroscopy: under intravenous sedation, hysteroscopic morcellation is perform after speculum insertion, vaginal cleansing, and paracervical anesthesia with xylocain 1%.
2. Vaginal hysteroscopy: under intravenous sedation, hysteroscopic morcellation is perform after vaginal cleansing using vaginal distension with saline solution
In addition to pain perception, other outcomes includes: complication rates, time to continue fertility treatment, time to pregnancy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard hysteroscopy
morcellation hysteroscopy with intravenous sedation and paracervical bloc
standard hysteroscopy
speculum, paracervical block before hysteroscopy morcellation
Vaginoscopy
morcellation hysteroscopy with only intravenous sedation
vaginoscopy
vaginal distension with hysteroscope for hysteroscopy morcellation (without speculum or tenaculum forceps)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vaginoscopy
vaginal distension with hysteroscope for hysteroscopy morcellation (without speculum or tenaculum forceps)
standard hysteroscopy
speculum, paracervical block before hysteroscopy morcellation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* polyp less than 2 cm
* submucosal fibroid (type 0 or 1 according to the 2011 FIGO uterine fibroid classification) less than 2 cm
* if more than 1 fibroid: total fibroid have to be less or equal 4 cm
Exclusion Criteria
* polyp or fibroid more than 2 cm
* pregnancy
* blood dyscrasia
18 Years
52 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hologic, Inc.
INDUSTRY
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carole KAMGA-NGANDE, MD
Role: PRINCIPAL_INVESTIGATOR
Centre hospitalier de l'Université de Montréal (CHUM)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHUM - Clinique Médecine et biologie de la reproduction
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19.380
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.